941 related articles for article (PubMed ID: 31767622)
1. G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.
Wendell SG; Fan H; Zhang C
Pharmacol Rev; 2020 Jan; 72(1):1-49. PubMed ID: 31767622
[TBL] [Abstract][Full Text] [Related]
2. Pepducins as a potential treatment strategy for asthma and COPD.
Panettieri RA; Pera T; Liggett SB; Benovic JL; Penn RB
Curr Opin Pharmacol; 2018 Jun; 40():120-125. PubMed ID: 29729548
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
Hay DW
Chest; 1997 Feb; 111(2 Suppl):35S-45S. PubMed ID: 9042025
[TBL] [Abstract][Full Text] [Related]
4. Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma.
Penn RB
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):149-69. PubMed ID: 18278482
[TBL] [Abstract][Full Text] [Related]
5. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
6. GPCRs and arrestins in airways: implications for asthma.
Penn RB; Bond RA; Walker JK
Handb Exp Pharmacol; 2014; 219():387-403. PubMed ID: 24292841
[TBL] [Abstract][Full Text] [Related]
7. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
Devillier P; Baccard N; Advenier C
Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
[TBL] [Abstract][Full Text] [Related]
8. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
9. Bitter taste receptors in the wrong place: novel airway smooth muscle targets for treating asthma.
Liggett SB
Trans Am Clin Climatol Assoc; 2014; 125():64-74; discussion 74-5. PubMed ID: 25125719
[TBL] [Abstract][Full Text] [Related]
10. Asthma therapy with agents preventing leukotriene synthesis or action.
Drazen JM
Proc Assoc Am Physicians; 1999; 111(6):547-59. PubMed ID: 10591083
[TBL] [Abstract][Full Text] [Related]
11. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
14. Bitter taste receptors in the treatment of asthma: Opportunities and challenges.
Camoretti-Mercado B; Lockey RF
J Allergy Clin Immunol; 2020 Oct; 146(4):776-779. PubMed ID: 32407838
[No Abstract] [Full Text] [Related]
15. Asthma treatment: antileukotriene drugs.
O'Byrne PM
Can Respir J; 1998; 5 Suppl A():64A-70A. PubMed ID: 9753521
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
17. Antileukotrienes in clinical development for asthma.
Centanni S; Santus P
Expert Opin Investig Drugs; 2002 Jan; 11(1):49-58. PubMed ID: 11772320
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene modifiers as novel therapeutics in asthma.
Leff JA
Clin Exp Allergy; 1998 Nov; 28 Suppl 5():147-53; discussion 171-3. PubMed ID: 9988461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
